Compare MTRN & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTRN | GRFS |
|---|---|---|
| Founded | 1931 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.4B |
| IPO Year | 2000 | N/A |
| Metric | MTRN | GRFS |
|---|---|---|
| Price | $274.46 | $7.37 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $52.50 | $10.15 |
| AVG Volume (30 Days) | 290.4K | ★ 521.9K |
| Earning Date | 04-29-2026 | 07-28-2022 |
| Dividend Yield | 0.32% | ★ 1.80% |
| EPS Growth | ★ 1178.57 | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.31 | $4.49 |
| Revenue Next Year | $7.57 | $6.42 |
| P/E Ratio | $296.77 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $76.09 | $7.26 |
| 52 Week High | $275.98 | $11.14 |
| Indicator | MTRN | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 80.15 | 39.71 |
| Support Level | $116.88 | $7.38 |
| Resistance Level | N/A | $8.88 |
| Average True Range (ATR) | 10.72 | 0.17 |
| MACD | 3.21 | 0.00 |
| Stochastic Oscillator | 97.57 | 20.90 |
Materion Corp offers products that include precious and non-precious specialty metals, inorganic chemicals and powders, specialty coatings, specialty engineered beryllium and copper-based alloys, beryllium composites, ceramics, and engineered clad and plated metal systems. Its segments are: Performance Materials provides beryllium and non-beryllium containing alloy systems and custom engineered parts. Electronic Materials produces chemicals, microelectronics packaging, and specialty metal products, including vapor deposition targets and preforms. Precision Optics produces thin film coatings and optical filter materials. The Other reportable segment includes unallocated corporate costs and assets. It operates in the United States, Asia, Europe, and other countries.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.